XML 31 R20.htm IDEA: XBRL DOCUMENT v3.19.1
Employee Benefits and Share-Based Compensation
3 Months Ended
Mar. 31, 2019
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Employee Benefits and Share-Based Compensation
Employee Benefits and Share-Based Compensation
Stock-Based Plans
For a detailed explanation of the Company's stock plans, please refer to Note 11, Employee Benefits and Share-Based Compensation, of the Company's annual report on Form 10-K for the year ended December 31, 2018 filed with the SEC on February 27, 2019.
Share-Based Compensation Expense
The following table sets forth the total share-based compensation expense recognized in the Company’s Condensed Consolidated Statements of Operations for the three months ended March 31, 2019 and 2018:
 
Three months ended
 
March 31, 2019
 
March 31, 2018
 
(In thousands)
Cost of product and service revenues
$
1,462

 
$
1,019

Research and development
1,702

 
1,234

Selling, general, and administrative
5,246

 
4,275

Total share-based compensation expense
$
8,410

 
$
6,528


In the first quarter of 2019, the Company modified the terms of its stock options by extending the post-employment exercise period for certain employees. The Company recorded share-based compensation expense related to this option modification of approximately $0.2 million during the three months ended March 31, 2019. The Company will incur an additional $0.8 million of share-based compensation expense for the impacted options over the remaining weighted-average vesting periods of 1.9 years.
Stock Options and ESPP Shares
The following assumptions were used to value stock options and Employee Stock Purchase Plan (“ESPP”) shares granted pursuant to the Company’s equity incentive plans for the three months ended March 31, 2019 and 2018:
 
Three months ended
 
March 31, 2019
 
March 31, 2018
Stock options
 
 
 
Expected life, years
4.5

 
4.8

Expected volatility, %
33.1
%
 
32.2
%
Risk-free interest rate, %
2.6
%
 
2.6
%
Estimated forfeiture rate, %
7.2
%
 
6.9
%
Dividend yield, %
%
 
%

 
Three months ended
 
March 31, 2019
 
March 31, 2018
Employee stock purchase plan shares
 
 
 
Expected life, years
0.5 - 2.0

 
0.5 - 2.0

Expected volatility, %
28.2% - 38.4%

 
27.7% - 33.8%

Risk-free interest rate, %
1.3% - 2.7%

 
0.7% - 2.3%

Dividend yield, %
%
 
%

Stock Options Activity
The following table summarizes the share option activity under the Company’s equity incentive plans during the three months ended March 31, 2019:
 
Number of
Shares
 
Weighted-Average
Exercise Price
 
Weighted-Average
Remaining Years
 
Aggregate
Intrinsic Value
 
(In thousands, except per share data)
Outstanding at December 31, 2018
3,748

 
$
41.27

 
7.6
 
$
78,365

Granted
292

 
76.18

 
 
 
 
Exercised
(379
)
 
31.83

 
 
 
 
Expired

 

 
 
 
 
Forfeited
(117
)
 
44.18

 
 
 
 
Outstanding at March 31, 2019
3,544

 
$
45.06

 
7.9
 
$
127,007

Exercisable at March 31, 2019
1,275

 
$
31.24

 
6.3
 
$
63,241

Vested and expected to vest at March 31, 2019 and thereafter
3,544

 
$
45.06

 
7.9
 
$
127,007


The weighted-average fair value per share of options granted during the three months ended March 31, 2019 and 2018 was $24.07 and $14.22, respectively. The intrinsic value of options exercised during the three months ended March 31, 2019 and 2018 was $17.1 million and $2.0 million, respectively.
As of March 31, 2019, total unrecognized compensation cost related to unvested stock options was $32.5 million, which is expected to be recognized over a weighted-average vesting period of 2.9 years.
Employee Stock Purchase Plan Activity
For the three months ended March 31, 2019 and 2018, employees purchased approximately 210,000 and 289,000 shares of common stock, respectively, under the ESPP at weighted average prices of $40.20 and $26.30, respectively. As of March 31, 2019, the unrecognized compensation cost related to the shares to be purchased under the ESPP was approximately $3.9 million and is expected to be recognized over a weighted-average period of 1.5 years.
Restricted Stock Units (“RSUs”) and Restricted Stock Awards (“RSAs”)
Summaries of the restricted stock activity under the Company’s 2009 Equity Incentive Plan, as amended (the “2009 Plan”) are presented below for the three months ended March 31, 2019:
 
Number of
Shares
 
Weighted-Average
Grant Date Fair Value
 
Weighted-Average
Remaining Years
 
Aggregate
Intrinsic Value
 
(In thousands, except per share data)
Restricted stock units
 
 
 
 
 
 
 
Outstanding at December 31, 2018
538

 
$
51.52

 
1.6
 
$
32,935

Granted (Awarded)
30

 
78.23

 
 
 
 
Vested (Released)
(36
)
 
39.78

 
 
 
 
Forfeited
(27
)
 
44.87

 
 
 
 
Outstanding and unvested at March 31, 2019
505

 
$
54.32

 
1.5
 
$
40,813


As of March 31, 2019, total unrecognized compensation cost related to RSUs was $23.4 million, which is expected to be recognized over the remaining weighted-average vesting period of 2.7 years.
 
Number of
Shares
 
Weighted-Average
Grant Date Fair Value
 
(In thousands, except per share data)
Restricted stock awards
 
 
 
Outstanding at December 31, 2018
21

 
$
46.60

Granted (Awarded)

 

Vested (Released)

 

Forfeited

 

Outstanding and unvested at March 31, 2019
21

 
$
46.60


As of March 31, 2019, total unrecognized compensation cost related to RSAs was $0.1 million, which is expected to be recognized over the remaining weighted-average vesting period of 0.1 years.
Performance-Based Restricted Stock Units
A summary of the performance-based restricted stock activity under the 2009 Plan is presented below for the three months ended March 31, 2019:
 
Number of
Shares
 
Weighted-Average
Grant Date Fair Value Per Unit
 
(In thousands, except per share data)
Outstanding at December 31, 2018
197

 
$
34.83

Granted
61

 
72.02

Vested
(26
)
 
38.03

Forfeited
(20
)
 
34.37

Outstanding and unvested at March 31, 2019
212

 
$
45.18


As of March 31, 2019, total unrecognized compensation cost related to PSUs was approximately $5.3 million, which is expected to be recognized over the remaining weighted-average period of 1.3 years.
Summary of Shares Reserved for Future Issuance under Equity Incentive Plans
The Company had the following ordinary shares reserved for future issuance under its equity incentive plans as of March 31, 2019:
 
Number of Shares
 
(In thousands)
Share options outstanding
3,544

Non-vested restricted share awards
738

Shares authorized for future issuance
2,140

ESPP shares available for future issuance
1,703

Total shares reserved for future issuance
8,125


Stock Repurchase Program
On August 2, 2016, the Company's Board of Directors (the “Board”) authorized a stock repurchase program providing for the repurchase of up to $50.0 million of the Company’s common stock (the “2016 Repurchase Program”). The 2016 Repurchase Program is in addition to the stock repurchase program approved by the Board on November 4, 2014 (the “2014 Repurchase Program”). As of March 31, 2019, the maximum dollar value of shares that may yet be purchased under the two repurchase programs was $54.9 million. The stock repurchase programs do not obligate the Company to repurchase any specific number of shares, and the Company may terminate or suspend the repurchase programs at any time.
During the three months ended March 31, 2019 and 2018, the Company did not repurchase any of its outstanding common stock.